The US Federal Reserve left interest rates unchanged at this week’s meeting, but announced that it will begin reducing its balance sheet next month.
How did life science stocks respond to yesterday’s rate hike? And more importantly, what will this mean for the healthcare sector going forward?
By Pia Rivera
David Morgan, author of the Morgan Report, spoke to INN about the precious metals market after the US presidential elections, the silver fix, and the effect of a possible Fed rate hike.
Connect with our Featured Silver Stocks to receive the latest news and investor presentations.